Table 3.
Correlation between clinicopathologic factors and pancreatic cancer patient subgroups (diagnosis of pancreatic cancer first vs. other 3 groups)
| Characteristic | Diagnosis of pancreatic cancer first (n=19) | Pancreatic cancer, merged other 3 groups (n=912) | p-value |
|---|---|---|---|
| Age, mean±SD (yr) | 59.2±9.2 | 59.8±9.8 | 0.702 |
| Sex | |||
| Male | 16 (84.2) | 552 (60.5) | 0.054 |
| Female | 3 (15.8) | 360 (39.5) | |
| pT category of pancreatic cancer | |||
| pT1 | 1 (5.3) | 13 (1.4) | 0.401 |
| pT2 | 1 (5.3) | 26 (2.9) | |
| pT3 | 17 (89.5) | 838 (91.9) | |
| pT4 | 0 | 35 (3.8) | |
| pN category of pancreatic cancer | |||
| pN0 | 9 (52.9) | 383 (43.0) | 0.464 |
| pN1 | 8 (47.1) | 508 (57.0) | |
| M category of pancreatic cancer | |||
| pM0 | 19 (100) | 872 (95.6) | 1.000 |
| pM1 | 0 | 40 (4.4) | |
| Lymphovascular invasion | |||
| Absent | 10 (55.6) | 536 (59.6) | 0.810 |
| Present | 8 (44.4) | 364 (40.4) | |
| Perineural invasion | |||
| Absent | 9 (60.0) | 132 (16.2) | < 0.001 |
| Present | 6 (40.0) | 681 (83.8) | |
| Differentiation | |||
| Well | 3 (18.8) | 88 (10.0) | 0.516 |
| Moderate | 11 (68.8) | 671 (76.2) | |
| Poor | 2 (12.5) | 122 (13.8) | |
| Treatment | |||
| Surgery | 6 (31.6) | 341 (37.4) | 0.931 |
| Surgery with CTx | 10 (52.6) | 449 (49.2) | |
| Surgery with RTx | 0 | 5 (0.5) | |
| Surgery with CTx+RTx | 3 (15.8) | 117 (12.8) |
Values are presented as number (%) unless otherwise indicated. SD, standard deviation; CTx, chemotherapy; RTx, radiation therapy.